#United States #Carmel #Syra Health #Healthcare Solutions #Profitable Growth

Syra Health Achieves New Milestones in Q3 2026

Syra Health Corp. (OTCQB: SYRA) has recently announced its financial results for the third quarter of 2026, marking a significant turning point in the company’s history. The organization, renowned for offering integrated healthcare solutions, reported an astounding 52% growth in revenue compared to the same period last year, reaching $2.6 million. Additionally, gross margins climbed to a record 46.3%, showcasing a remarkable improvement from 32.9% a year earlier.

Financial Performance Overview

The latest financial results reflect that Syra Health successfully navigated the healthcare landscape, turning previous losses into net income of $344,610, a significant improvement from a net loss of $225,902 in Q3 2025. This turnaround speaks volumes about the company’s robust operational strategies and commitment to enhancing health outcomes through affordable solutions. The company has shown a continuous trend of profitability over the past three quarters, with earnings per share (EPS) bouncing back to $0.02 compared to a loss of $(0.02) a year prior.

Record Gross Margin

The impressive gross margin of 46.3% during Q3 2026 exemplifies the successful balance between revenue growth and effective cost management. Gross margins improved by 1,340 basis points year-on-year, propelled by a favorable revenue mix and operational advantages. The revenues primarily stemmed from Syra Health’s population health solutions, which also recorded a 52% growth, affirming the demand for such services in a changing healthcare environment.

Operational Highlights

Apart from the positive financial trajectory, Syra Health has effectively expanded its services with managed care organizations, addressing healthcare needs for numerous Medicaid recipients. Key operational developments include initiatives aimed at enhancing data collection, analysis, and reporting on claims. The addition of a live-agent call center has also improved service delivery, allowing for optimized quality measures and expedited care processes.

Further, with the Centers for Medicare & Medicaid Services (CMS) granting approval for Syrenity under the ACCESS Model, Syra Health is actively recruiting Accountable Care Organizations (ACOs) to leverage its innovative mental and behavioral health solution, which is expected to cultivate steady revenue channels in the coming years.

Growth Strategy and Future Outlook

Greg Alexander, CEO of Syra Health, expressed his confidence in the continued growth and profitability trajectory of the company, stating, “Q3 2026 signifies our third consecutive profitable quarter, confirming that we have transformed into a profitable growth company.” The company is strategically focusing on high-value solutions within population health and better-margin contracts, reflecting a disciplined approach to business management and investment.

Financial Projections

Looking at the full-year outlook for 2026, Syra Health is poised to maintain its profitability. The effective management of resources has led to a cash flow of $975,023 from operations during the first nine months of 2026, further strengthening its financial footing with a cash reserve of $2.4 million and no long-term debt.

Concluding Remarks

As Syra Health continues to pave the way in the healthcare sector, the results of Q3 2026 have solidified its position as a key player in improving health outcomes. With strategic investments and an expanding portfolio of healthcare solutions, Syra Health is not only focused on achieving profitability but also dedicated to building long-term value for all stakeholders involved. Maintaining a commitment to both their customers and shareholders, the company is indeed optimistic about what lies ahead.